LLTP Financials 07/16/2014 17:56:04 Lightlake The

LLTP Financials 07/16/2014 17:56:04
Lightlake Therapeutics
Period Ending Jul 31, 2013 Jul 31, 2012 Jul 31, 2011 Jul 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 283 506 - -
Sales, General and Admin. 4,002 11,830 9,436 2,017
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,285) (12,336) (9,436) (2,017)
Income From Continuing Operations
Add'l Income/Expense Items 182 (24) - -
Earnings Before Interest and Tax (4,102) (12,360) (9,436) (2,017)
Interest Expense 553 61 - -
Earnings Before Tax (4,655) (12,421) (9,436) (2,017)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,655) (12,421) (9,436) (2,017)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,655) (12,421) (9,436) (2,017)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,655) (12,421) (9,436) (2,017)